These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reaction Kinetics using a Chemputable Framework for Data Collection and Analysis. Matysiak BM; Thomas D; Cronin L Angew Chem Int Ed Engl; 2024 Feb; 63(9):e202315207. PubMed ID: 38155102 [TBL] [Abstract][Full Text] [Related]
5. Progress and prospects for accelerating materials science with automated and autonomous workflows. Stein HS; Gregoire JM Chem Sci; 2019 Nov; 10(42):9640-9649. PubMed ID: 32153744 [TBL] [Abstract][Full Text] [Related]
6. A biofoundry workflow for the identification of genetic determinants of microbial growth inhibition. Moffat AD; Elliston A; Patron NJ; Truman AW; Carrasco Lopez JA Synth Biol (Oxf); 2021; 6(1):ysab004. PubMed ID: 33623825 [TBL] [Abstract][Full Text] [Related]
7. High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow. Ozik J; Collier N; Wozniak JM; Macal C; Cockrell C; Friedman SH; Ghaffarizadeh A; Heiland R; An G; Macklin P BMC Bioinformatics; 2018 Dec; 19(Suppl 18):483. PubMed ID: 30577742 [TBL] [Abstract][Full Text] [Related]
8. An Automated Robotic Interface for Assays: Facilitating Machine Learning in Drug Discovery by the Automation of Physicochemical Property Assays. Wu NP; Wang W; Gadiagellan D; Counsell M; Hamidi NK; Koike Y; Nguyen HQ ACS Omega; 2024 Jun; 9(23):24948-24958. PubMed ID: 38882107 [TBL] [Abstract][Full Text] [Related]
12. High-Throughput Purification in Drug Discovery: Scaling New Heights of Productivity. Jones M; Goodyear RL ACS Med Chem Lett; 2023 Jul; 14(7):916-919. PubMed ID: 37465307 [TBL] [Abstract][Full Text] [Related]
13. How the Monty Hall problem is similar to the false discovery rate in high-throughput data analysis. Li JJ Nat Biotechnol; 2023 Jun; 41(6):754-755. PubMed ID: 37198440 [No Abstract] [Full Text] [Related]
14. Correction to "Random control selection for conducting high-throughput adverse drug events screening using large-scale longitudinal health data". CPT Pharmacometrics Syst Pharmacol; 2024 Jul; 13(7):1280. PubMed ID: 38938014 [No Abstract] [Full Text] [Related]
15. High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery. Srinivasan B; Flórez Weidinger JD; Zhai X; Lemercier G; Ikeda T; Brewer M; Zhang B; Heyse S; Wingfield J; Steigele S SLAS Discov; 2022 Dec; 27(8):460-470. PubMed ID: 36156314 [TBL] [Abstract][Full Text] [Related]
16. A robust CETSA data analysis automation workflow for routine screening. Florez Weidinger JD; Pfreundschuh M; Zörb D; Yee A; Heyse S; Bärenz F; Steigele S SLAS Discov; 2024 Jul; 29(5):100172. PubMed ID: 38969289 [TBL] [Abstract][Full Text] [Related]
17. Non-equilibrium modalities of inhibition: Characterizing irreversible inhibition for the ErbB receptor family members. Srinivasan B Methods Enzymol; 2023; 690():85-108. PubMed ID: 37858541 [TBL] [Abstract][Full Text] [Related]